-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medtronic announced today that it has entered into a definitive agreement to acquire Affera, a medical technology company
The acquisition expands Medtronic's portfolio of cardiac ablation products and accessories to meet the needs of a growing patient population
According to reports, the prevalence of cardiac arrhythmias is growing rapidly within the $8 billion global Electrophysiology (EP, Electrical Physiology) ablation market, with an increasing number of patient populations (including AF, supraventricular tachycardia (SVT) ) and ventricular tachycardia (VT)) are also increasing the need for treatment
Original in English: https:// href="https://" target="_blank" _href="https://">https://